ALDEYRA THERAPEUTICS, INC. Proceeds from Long-Term Debt Issued
ALDEYRA THERAPEUTICS, INC. (ALDX) reported Proceeds from Long-Term Debt Issued of $14.45 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2021-03-11
- ALDEYRA THERAPEUTICS, INC. proceeds from issuance of long-term debt for the quarter ending 2019-12-31 was $0.00.
- ALDEYRA THERAPEUTICS, INC. proceeds from issuance of long-term debt for fiscal 2019 was $14.45M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $14.45M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $14.45M 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |